{{Drugbox
| drug_name = 
| IUPAC_name        = 2,3-Dihydroxypropyl 2-<nowiki/>{[8-(trifluoromethyl)-4-quinolinyl]amino}benzoate
| image             = Floctafenine.svg
| alt               = 
| caption           =

<!-- Clinical data -->
| tradename         = 
| Drugs.com         = {{Drugs.com|international|floctafenine}}
| MedlinePlus       = 
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US      = <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status      = 
| routes_of_administration =

<!-- Pharmacokinetic data -->
| bioavailability   = 
| protein_bound     = 
| metabolism        = 
| elimination_half-life = 
| excretion         =

<!-- Identifiers -->
| CAS_number        = 23779-99-9
| ATCvet            = 
| ATC_prefix        = N02
| ATC_suffix        = BG04
| PubChem           = 3360
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08976
|  ChemSpiderID = 3243

<!-- Chemical data -->
| C=20 | H=17 | F=3 | N=2 | O=4
| molecular_weight  = 406.355 g/mol
| smiles            = FC(F)(F)c1cccc2c(ccnc12)Nc3ccccc3C(=O)OCC(O)CO
| StdInChI          = 1S/C20H17F3N2O4/c21-20(22,23)15-6-3-5-13-17(8-9-24-18(13)15)25-16-7-2-1-4-14(16)19(28)29-11-12(27)10-26/h1-9,12,26-27H,10-11H2,(H,24,25)
| StdInChIKey       = APQPGQGAWABJLN-UHFFFAOYSA-N
}}

'''Floctafenine''' is a [[nonsteroidal anti-inflammatory drug]] (NSAID).

==Synthesis==
[[File:Flocatfenine synthesis.svg|thumb|center|700px|Flocatfenine synthesis: {{Cite patent|DE|1815467}}; eidem, {{US patent|3644368}} [[Roussel Uclaf]];<ref>{{Cite journal | doi = 10.1055/s-1980-28923| title = A New, Convenient Synthesis of Glafenine and Floctafenine| journal = Synthesis| volume = 1980| pages = 54| year = 1980| last1 = Mouzin | first1 = G. | last2 = Cousse | first2 = H. | last3 = Autin | first3 = J. M. }}</ref>]]

The scheme involves first the conversion of ortho-trifluoromethyl aniline ('''1''') to a [[quinolol]]. The compound is thus condensed with [[EMME]] ([[Ethoxy Methylene Malonic Diethyl Ester]]) and cyclized thermally ('''2'''). That intermediate is then [[saponified]]; the resulting acid is [[decarboxylated]] and finally converted to the 4-chloroquinoline ('''3''') by reaction with [[phosphorus oxychloride]]. The displacement of chlorine with [[methyl anthranilate]] ('''4''') then affords the coupled intermediate ('''5'''). An ester interchange of that product with [[glycerol]] leads to the glyceryl ester. There is thus obtained the [[NSAID]] floctafenine.

==See also==
* [[Glafenine]], a chemically related NSAID

==References==
{{reflist}}

{{Anti-inflammatory products}}
{{Prostanoidergics}}

[[Category:Nonsteroidal anti-inflammatory drugs]]
[[Category:Quinolines]]
[[Category:Vicinal diols]]
[[Category:Trifluoromethyl compounds]]
[[Category:Anthranilates]]


{{analgesic-stub}}